DGAP-Adhoc: 4basebio AG: 4basebio AG decides to increase the public share buyback offer volume from 2,056,452 to 5,230,726 shares

2020. február 10., hétfő, 11:30





DGAP-Ad-hoc: 4basebio AG / Key word(s): Share Buyback


4basebio AG: 4basebio AG decides to increase the public share buyback offer volume from 2,056,452 to 5,230,726 shares


10-Feb-2020 / 11:30 CET/CEST


Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.


The issuer is solely responsible for the content of this announcement.




Ad hoc Release according to Art. 17 Market Abuse Regulation



4basebio AG decides to increase the public share buyback offer volume from 2,056,452 to 5,230,726 shares



Heidelberg, Germany, and Cambridge, UK, 10 February 2020 - The management board of 4basebio AG (formerly Expedeon AG) (Frankfurt: 4BSB; ISIN: DE000A2YN801; Prime Standard) has decided today, to increase the original volume of the current public share buyback offer from 2,056,452 to 5,230,726 shares and thus to acquire now shares up to 5,230,726.



The acceptance period ends on 10 February 2020, 12:00 noon (local time Frankfurt am Main). If more than 5,230,726 shares are submitted for buyback under the offer, the declarations of acceptance will be considered in proportion to the ratio of the 5,230,726 shares to the total number of shares submitted for buyback by the shareholders.



Further details of the public buyback offer can be found in the offer document, which was published on 24 January 2020 on the Company"s website (www.investors.4basebio.com) under the heading "News" and in the German Federal Gazette (Bundesanzeiger).



*** end of ad hoc announcement ***



For further information, please contact:



4basebio AG

Dr. Heikki Lanckriet

CEO/CSO

Phone: +44 1223 873 364

Email: heikki.lanckriet@4basebio.com

Investors" information: investors.4basebio.com



MC Services AG (Investor Relations and International Media Relations)



Julia Hofmann

Phone: +49 89 210228 0

Email: 4basebio@mc-services.eu



### This publication is intended for information only and constitutes neither an offer to sell nor an invitation to buy securities. Some statements included in this press release, relating neither to proven financial results nor other historical data, should be viewed as forward-looking, i.e. not definite. Such statements are mainly predictions of future results, trends, plans or goals. These statements should not be considered to be total guarantees since given their very nature they are subject to known and unknown risks and imponderability and can be affected by other factors as a consequence of which the actual results, plans and goals of 4basebio AG may deviate greatly from the established conclusions or implied predictions contained in such statements. 4basebio does not undertake to publicly update or revise these statements in the light of new information or future results or for any other reason. ###






Contact:

David Roth

Vorstand/ CFO


Expedeon AG


Waldhofer Str. 102

69123 Heidelberg, GERMANY


Tel. +49 6221 3540 125

Fax. +49 6221 3540 127








10-Feb-2020 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de



























Language: English
Company: 4basebio AG

Waldhofer Str. 102

69123 Heidelberg

Germany
Phone: +49 (0) 6221 3540 125
Fax: +49 (0) 6221 3540 127
E-mail: 4basebio@expedeon.com
Internet: www.4basebio.com
ISIN: DE000A2YN801
WKN: A2YN80
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 971533





 
End of Announcement DGAP News Service




971533  10-Feb-2020 CET/CEST







fncls.ssp?fn=show_t_gif&application_id=971533&application_name=news&site_id=geo_holding_tug
Tilos a hír bármilyen adatbázisba történő mentése vagy annak továbbítása harmadik fél számára;kereskedelmi viszonylatban vagy kereskedelmi céllal csak a Deutsche Gesellschaft für Ad-hoc-Publizität mbh írásos engedélyével történhet.

Közzétételek - archívum